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Abstract 
Background: Bloodstream infections (BSI) and delirium are frequent in critically ill patients. During systemic inflam‑
matory response to BSI, cytokines may interact with neurotransmitters and neuronal receptors driving acute brain 
dysfunction. However, prospectively collected data on incidence, prediction and impact of delirium in association 
with BSI are lacking. This study aimed to determine the incidence and predictors of new‑onset delirium and its impact 
on outcome in critically ill adult patients with BSI.
Methods: From 2011 to 2014, all consecutive adult patients with BSI treated in the intensive care units of an aca‑
demic medical care center were identified. Pertinent clinical and microbiological data including the Intensive Care 
Delirium Screening Checklist (ICDSC) were assessed. Multivariable analysis was performed to identify variables inde‑
pendently associated with ICDSC ≥4.
Results: Among 240 patients, 145 (60%) had an ICDSC ≥4 (i.e., delirium). In‑hospital mortality was 34%. Delirious 
patients had a higher mortality (40 vs. 23%; p = 0.005), a lower proportion with return to functional baseline (30 vs. 
46%; p = 0.012), and a higher proportion with unfavorable outcome in survivors (74 vs. 54%; p = 0.010). Multivariable 
analyses revealed age (OR 1.04, 95% CI 1.02–1.06), male gender (OR 2.26, 95% CI 1.17–4.36), and the number of cath‑
eters and drainages before diagnosis of BSI (OR for every additional catheter = 1.14, 95% CI 1.04–1.25) as independent 
predictors for delirium (adjusted for SAPS [simplified acute physiology score] II, Riker Sedation‑Agitation Scale [SAS], 
Sequential Organ Failure Assessment [SOFA] score, dementia and/or leukoencephalopathy, and albumin levels).
Conclusions: The incidence of delirium in patients with BSI is high and associated with adverse outcome. The num‑
ber of catheters and drainages may constitute a useful and readily available predictor of delirium in patients with BSI 
allowing to identify patients at high risk. Ultimately, reliable identification of patients at increased risk for delirium is 
key for allocation of specific prevention strategies.
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Background
Sepsis and delirium are frequent and associated with high 
morbidity and mortality in critically ill patients treated in 
intensive care units (ICUs) [1, 2]. Sepsis affects more than 
25% [3–5], and delirium is present in as many as 80% of 
mechanically ventilated patients [6–8] and in up to 50% of 
non-mechanically ventilated patients [9–11]. They often 
concur, and a number of recent studies provide evidence of 
complex underlying mechanisms explaining how systemic 
inflammatory response drives acute brain dysfunction, pos-
sibly explaining this association. Systemic inflammation 
may disturb the integrity of the central nervous system by 
an increased production and release of cytokines inter-
acting with the somatic autonomic nerve fibers. Associ-
ated changes in brain perfusion, and increased diffusion of 
cytokines through the loosened blood–brain barrier mainly 
in the circumventricular areas, the choroid plexus [12], or 
through saturable transport mechanisms [13] may further 
fuel these interactions. In addition, anorexia, lethargy, and 
depression in temporal association with systemic inflam-
mation and fever, collectively named sickness behavior, are 
observed as a response of neurons to cytokines in different 
animal models [14, 15] and humans [16]. Although it seems 
evident that activation of the immune system can induce 
acute brain dysfunction and that sepsis, therefore, is a major 
risk factor for delirium, most studies are hampered by the 
fact that sepsis encompasses a variety of different sources 
and states of infection and do not focus on the immediate 
and acute neurological impact of specific infections in criti-
cal care settings. Although bloodstream infections (BSI) 
belong to the most important, frequent, and clearly defined 
infections encountered in ICUs, prospective studies regard-
ing the incidence, prediction, and impact of delirium in 
association with BSI are not yet published.
We therefore sought to determine incidence and pre-
dictors of new-onset delirium and its impact on outcome 
in critically ill adult patients with BSI.
Methods
This study was performed in the ICUs of the University 
Hospital Basel, Switzerland, an academic tertiary medical 
care center treating more than 47,000 emergencies and 
with more than 35,000 admissions per year. Patients were 
derived from an ongoing prospective cohort of patients 
with BSI [17].
The study was approved by the local ethics committee 
(Ethikkommission Nordwest-und Zentralschweiz, Nr. 
2014/165) according to the declaration of Helsinki, and 
patients’ consent was waived.
Demographics and clinical characteristics
From 2011 to 2014, all consecutive adult  patients 
with BSI treated in the medical or surgical ICUs of an 
academic medical care center were identified. Patients 
without consecutive ICDSC scoring or with delirium 
prior to the diagnosis of BSI were excluded. We assessed 
pertinent clinical, laboratory, and microbiological data 
including principal diagnoses, the SAPS II scores, comor-
bidities, transient episodes of coma on the day of BSI 
diagnosis, and serum levels of acute-phase proteins as 
described below. Treatment characteristics of all patients 
were assessed including ICU and hospital stay, dura-
tion of mechanical ventilation, the number of catheters 
and drainages, the use of anesthetics and sedatives dur-
ing the three days prior to BSI, and the administration of 
anesthetics and neuroleptic drugs during the three days 
following BSI. The Intensive Care Delirium Screening 
Checklist (ICDSC) and outcomes were assessed as men-
tioned below.
Sedation protocol
In all patients treated with sedatives, sedation was man-
aged and titrated by using the Riker Sedation-Agitation 
Scale (SAS). In all patients treated with sedatives, daily 
interruption of sedation was an integral component 
of the sedation protocol. To establish sedation, short 
active sedatives such as disoprivan were preferred pro-
viding absence of hemodynamic instability. In patients 
with hemodynamic instability, sedation was achieved by 
administration of benzodiazepines given at the lowest 
possible dose and titrated according to the sedation level 
as determined by SAS.
Definition and detection of infections and BSIs
A protocol for monitoring infections was established for 
all patients in the ICUs during the entire study period. It 
included drawing cultures of blood and urine, cultures 
from tracheal aspirates or sputum, and performance of 
a chest X-ray in any patient with new onset of fever or 
hypothermia. If other foci were suspected, these were 
sampled accordingly. Infections were diagnosed based 
on the patients’ clinical examination, radiological exams, 
laboratory findings, and microbiological results according 
to the Centers for Disease Control and Prevention (CDC) 
criteria [18]. The diagnosis of BSI was defined accord-
ing to the current guidelines [19] and confirmed by two 
infectious diseases specialists in patients with at least 
one positive blood culture and concurrent presence of 
the systemic inflammatory response syndrome. Systemic 
inflammatory response was diagnosed if two or more of 
the following criteria were fulfilled: body temperature >38 
or <36  °C; heart rate >90/min; respiratory rate >20/min; 
serum leukocyte count >12 or <4 G/L or the presence 
of >10% immature neutrophil granulocytes in the blood 
samples. Catheter-related BSI was defined according to 
the CDC criteria (www.cdc.gov/hai/bsi/bsi.html).
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New definitions for sepsis and septic shock were pub-
lished in 2016 [20], recommending to define sepsis as 
life-threatening organ dysfunction, captured by the 
Sequential [Sepsis-related] Organ Failure Assessment 
(SOFA) score, and defining septic shock as the need for 
vasopressors to maintain a mean arterial blood pressure 
of ≥65 mmHg and serum lactate level >2 mmol/L in the 
absence of hypovolemia. Therefore, we retrospectively 
collected the respective information to calculate the 
SOFA score and to identify septic shock accordingly.
Definition and detection of new‑onset delirium
Among several screening methods to detect delirium in 
ICUs, the Confusion Assessment Method for the ICU 
(CAM-ICU) [6] and the Intensive Care Delirium Screen-
ing Checklist (ICDSC) [9] have been most frequently 
employed. Both have been recommended for the screen-
ing of delirium in ICUs by the Society of Critical Care 
Medicine based on high-quality evidence. [21] Direct 
comparisons of the diagnostic accuracy of the CAM-ICU 
and the ICDSC have been performed in recent studies 
with heterogenous ICU populations revealing a higher 
sensitivity and specificity of the ICDSC than the CAM-
ICU [22–24].
Based on these data, in our institution, the ICDSC is 
daily assessed in all ICU patients. For the present study, 
the ICDSC scores on the day before, the day of, and the 
day following diagnosis of BSI were used. To reduce 
the interference of sedation in mechanically venti-
lated patients, ICDSC assessments were performed in 
mechanically ventilated patients after routine daily inter-
ruption of sedation at our institution.
According to the studies and guidelines mentioned 
above, an ICDSC ≥4 was defined as delirium [9, 21].
Measurements of acute‑phase proteins
For the present study, serum levels of acute-phase pro-
teins (including CRP [C-reactive protein] and albumin), 
measured daily in all consecutive patients during the 
study period, were included on the day before, the day 
of, and the day following the diagnosis of BSI. CRP con-
centrations were determined by an enzyme immunoassay 
with a detection limit of 0.5  mg/l (EMIT; Merck Diag-
nostica, Switzerland). Values <10 mg/l are considered as 
normal.
Outcomes
The primary outcome was the development of delirium 
±24 h around the diagnosis of BSI. Secondary outcomes 
were death during the same hospital stay, and return to 
functional baseline and unfavorable outcome in survivors 
defined as a Glasgow Outcome Score (GOS) of 1–3 at 
discharge.
Statistics
The Chi-square and Fisher exact test (where appropriate) 
were used for comparisons of proportions. For continu-
ous variables, the Shapiro–Wilk test was used to dis-
tinguish between normal and abnormal distributions. 
Normally distributed variables were analyzed using the 
Student’s t test and non-normally distributed variables 
using the Mann–Whitney U test. To address possible 
confounding, all variables found to be significant in uni-
variable analyses and known risk factors (i.e., SAPS II, 
dementia/leukoencephalopathy) were included in the 
multivariable regression models after calculating odds 
ratios by logistic regression. In addition, SAS and SOFA 
were included into the multivariable logistic regression 
model to correct for the effects of sedation and organ 
failure on ICDSC scores [25]. Stepwise logistic regression 
using stepwise forward and backward selection, as well as 
Akaike information criterion (AIC), was applied to iden-
tify variables independently associated with ICDSC ≥4, 
and collinearity between covariates was assessed.
The Hosmer–Lemeshow goodness-of-fit test was 
applied to check the final models. Areas under the 
receiver operating characteristic (ROC) curve were cal-
culated for the final models to evaluate discrimination.
Two-sided p values ≤0.05 were considered statisti-
cally significant. Statistical analyses were performed with 
STATA® version 13.0 (Stata Corp., College Station, TX).
Results
A total of 309 patients with BSI fulfilled the study crite-
ria: 69 patients without consecutive ICDSC scores on all 
three defined days or with delirium prior to the diagnosis 
of BSI were excluded. There was no significant difference 
regarding all baseline characteristics, complications, and 
outcomes between the excluded and included patients. 
In the remaining 240 patients, median age was 68 years 
(interquartile range [IQR] 58–77), median ICU stay was 
7  days (IQR 3–19), and median hospital stay 28  days 
(IQR 15–54). During intensive care, 141 patients (58.8%) 
were mechanically ventilated for a median of 8 days (IQR 
3–19) and the median number of catheters and drainages 
per patient was 6 (IQR 4–9).
New-onset delirium, defined as an ICDSC ≥4 ±  24  h 
around BSI diagnosis, was identified in 145 (60%) patients 
with BSI. The median duration of new-onset delirium 
was 4 days (IQR 2–8). The median time from admission 
to BSI and delirium was 7  days (IQR 2–16) and 8  days 
(IQR 2–19), respectively. Delirium emerged in most 
patients immediately before or together with the diagno-
sis of BSI (in 75 patients [51.7%] on the day before BSI, 
in 50 patients [34.5%] on the day of BSI diagnosis, and 
in 20 patients [13.8%] one day following BSI diagnosis). 
The distribution of the highest ICDSC ±24  h around 
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BSI diagnosis in patients with and without delirium is 
presented in Fig.  1. In delirious patients, 85.5% had an 
ICDSC of 4–6. The ICDSC of our patients with a ICDSC 
<4 was 1–3 in 72.6%, representing a significant propor-
tion of patients with “sub-syndromal delirium.” The use 
of anesthetics and sedatives three days prior to BSI did 
not significantly differ between patients with and without 
an ICDSC ≥4 (40 vs. 35.8%; p = 0.512). The univariable 
comparisons of demographics, baseline characteristics, 
and details regarding BSIs between patients with BSI with 
and without new-onset delirium are presented in Tables 1 
and 2. Among all patients with BSI, 92 (26.1%) developed 
septic shock. Serum levels of CRP and leukocytes on the 
day before, the day of, and the day after BSI diagnosis did 
not differ between delirious and non-delirious patients. 
Comparisons of treatment characteristics and outcomes 
are summarized in Table 3. In delirious patients, mortal-
ity was 33.8%. Delirious patients had an almost twofold 
increased mortality, a lower proportion with return to 
functional baseline, and a higher proportion with unfa-
vorable outcome in survivors, as compared to non-delir-
ious patients (Table  3). Multivariable analyses revealed 
that delirium was independently associated with death in 
our cohort (adjusting for well-established outcome pre-
dictors in ICU patients, such as age, SAPSII score, the 
Charlson Comorbidity Index, and albumin serum levels at 
admission, OR 1.90, 95% CI 1.01–3.63; p = 0.049). In uni-
variable analysis, delirious patients were older, more often 
male, had lower median albumin serum levels at admis-
sion, prolonged ICU stay, and had more catheters and 
drainages before the diagnosis of BSI (Tables 1, 3). Every 
additional catheter or drainage increased the probability 
of delirium (ORfor every catheter/drainage = 1.14, 95% CI 1.05–
1.24; p  =  0.002; Fig.  2). The number and duration of 
mechanical ventilation did not differ between patients 
with and without delirium (Table 3). The sources of BSI, 
the distribution of gram-positive and gram-negative path-
ogens, and the number of infectious complications did 
not differ significantly between patients with and without 
delirium (Table  2). Most BSIs were catheter-related not 
differing between patients with and without delirium.    
Uni- and multivariable logistic regression analyses 
including characteristics significantly differing between 
patients with and without delirium (Tables  1, 3), as well 
as established risk factors for delirium (i.e., SAPS II, 
dementia/leukoencephalopathy) and SAS and SOFA 
scores to correct for the effects of sedation and organ fail-
ure on ICDSC are shown in Table  4. All three stepwise 
selection approaches revealed older age, male gender, 
and the number of catheters and drainages as predictors 
for delirium, independent of possible confounders (i.e., 
age, gender, SAPS II, SAS, SOFA scores, dementia and/
or leukoencephalopathy, and albumin serum levels). The 
mean variance inflation factor for all variables included 
in the multivariable models was 1.26, ranging from 1.03 
to 1.68, ruling out high collinearity and indicating that 
the selected variables are independent from other pre-
dictors. The Hosmer–Lemeshow goodness-of-fit test for 
the model selection by AIC was χ2  =  4.67 (p  =  0.792) 
and for the stepwise forward and backward selection was 
χ2 = 9.45 (p = 0.306), indicating adequate model fit. The 
area under the ROC curve for the stepwise regression 
model was 0.072 supporting its ability to discriminate 
between patients with and without ICDSC ≥4 during BSI.
Fig. 1 Distribution of the maximal ICDSC ±24 h around diagnosis of bloodstream infections in patients with and without delirium. ICDSC the 
Intensive Care Delirium Screening Checklist
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Discussion
New-onset delirium in adult ICU patients with BSI is fre-
quent and associated with increased morbidity and mor-
tality. In our study,  the incidence of new-onset delirium 
in close temporal association with BSI diagnosis (60%) 
is in the upper range of the incidence in the general ICU 
population (23–65%) [26], suggesting that BSI in critically 
ill patients may have a promotional effect on the develop-
ment of delirium. In addition, the ICDSC of our patients 
with an ICDSC <4 was 1–3 in 72.6%, representing a 
Table 1 Univariable comparisons of  baseline characteristics between  ICU patients with  and without  ICDSC ≥4 dur-
ing bloodstream infections (n = 240)
Patient’s characteristics BSI patients with  
ICDSC <4 (n = 95)




 Age (years; median, IQR) 63 48–72 70 60–78 <0.001
 Female (n, %) 40 42.1 39 26.9 0.014
 Male (n, %) 55 57.9 106 73.1
Clinical features
 SAPS II (median, IQR) 47 34–64 52 38–69 0.070
 Main principal diagnoses (n, %) not mutual exclusive
  Cardiac disease 58 61.1 103 71.0 0.108
  Pulmonary disease (other than ARDS/ALI) 58 61.1 76 52.4 0.188
  ARDS/ALI 9 9.5 10 6.9 0.474*
  Gastrointestinal tract disease 46 48.4 74 51.0 0.692
  Acute ischemic stroke 7 7.4 17 11.7 0.379*
  Seizure or status epilepticus 5 5.3 8 5.5
  Intracranial hemorrhage 3 3.2 6 4.1
  Polytrauma 5 5.3 4 2.8
  Traumatic brain injury 4 4.2 2 1.4
  Hypoxic ischemic encephalopathy 2 2.1 3 2.1
  Surgery 50 52.6 81 55.9 0.623
   Gastrointestinal tract surgery 19 20.0 17 11.7 0.079
   Cardiac surgery 4 4.2 13 9.0 0.203*
   Thoracic surgery 2 2.1 7 4.8
   Brain surgery 1 1.1 2 1.4
   Other surgery 24 25.3 42 29.0 0.530
  Cardiopulmonary resuscitation 16 16.8 34 23.5 0.218
 Comorbidities
  Charlson Comorbidity Index (median, IQR) 2 1–4 3 1–4 0.415
  Immunosuppression (n, %) 48 50.5 65 44.8 0.387
  Liver and/or renal insufficiency (n, %) 19 20 42 29 0.119
  Drug abuse (n, %) 10 10.5 28 19.3 0.068
  Remote ischemic stroke (n, %) 8 8.4 20 13.8 0.205
  Leukoencephalopathy (n, %) 3 3.2 10 6.9 0.256
  Dementia (n, %) 2 2.1 8 5.5 0.323
  Epilepsy (n, %) 3 3.2 3 2.1
  Remote cerebral hemorrhage (n, %) 1 1.1 5 3.5
  Chronic alcohol intake 1 1.1 4 2.8
Transient episodes of coma on day before BSI diagnosis 17 17.9 38 26.2 0.134
SAS (median, IQR) 3 2–4 3 3–5 0.104
C‑reactive protein (mg/l) Median IQR Median IQR
  C‑reactive protein on day before BSI diagnosis 113 41–209 121 73–225 0.299
  C‑reactive protein on day of BSI diagnosis 136 62–239 154 80–267 0.364
  C‑reactive protein on day after BSI diagnosis 159 82–281 178 103–285 0.409
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significant proportion of patients with “sub-syndromal 
delirium” in close temporal relation to BSI. Similar to 
published studies, our multivariable analyses confirm 
that established risk factors for acute brain dysfunction 
in critically ill patients including older age [26], male 
gender, and low serum levels of albumin [27] are predic-
tors of new-onset delirium in close temporal association 
with the diagnosis of BSI. Other well-known predictors 
for delirium in the general ICU population identified by 
a recent large systematic review [26] seem to have no sig-
nificant influence on the development of delirium in the 
context of BSI, such as altered level of consciousness, or 
surgery. However, interpretations regarding the associa-
tion between trauma and delirium in our study are ham-
pered, as patients with trauma are underrepresented in 
our cohort. The underlying mechanisms of male gender 
Table 1 continued
Patient’s characteristics BSI patients with  
ICDSC <4 (n = 95)




  Leukocytes on day before BSI diagnosis 12 8–18 12 8–16 0.862
  Leukocytes on day of BSI diagnosis 13 8–18 12 8–18 0.853
  Leukocytes on day after BSI diagnosis 12 7–18 13 9–18 0.147
Albumin (g/l)
  Albumin at admission 23 16–28 18 15–23 0.026
  Albumin on day of BSI diagnosis 21 16–26 18 14–23 0.045
BSI bloodstream infections, ICDSC Intensive Care Delirium Screening Checklist, MICU medical intensive care unit; SICU = surgical intensive care unit, ICU intensive care 
unit, SAPS simplified acute physiology score, ARDS acute respiratory distress syndrome, ALI acute lung injury, SAS Riker Sedation-Agitation Scale
* Fisher’s exact test; italic: p values are considered significant
Table 2 Univariable comparisons of  detailed characteristics of  bloodstream infections between  ICU patients with  and 
without ICDSC ≥4 (n = 240)
BSI bloodstream infections, ICDSC Intensive Care Delirium Screening Checklist, SOFA score Sequential [Sepsis-related] Organ Failure Assessment Score
* Fisher’s exact test; italic p values are considered significant
Patient’s characteristics BSI patients with ICDSC <4 (n = 95) BSI patients with ICDSC ≥4 (n = 145) p value
SOFA score (median, IQR) 6 3–9 7 4–10 0.052
Septic shock (n, %) 38 40.0 54 37.2 0.667
Source of BSI (n, %)
 Catheters 27 28.4 35 24.1 0.458
 Gastrointestinal tract 19 20.0 29 20.0 1.000
 Respiratory tract 17 17.9 27 18.6 0.887
 Intravascular/endocardial 10 10.5 6 4.1 0.065
 Urogenital tract 5 5.3 8 5.5 0.932
 Skin/soft tissue 3 3.2 9 6.2 0.373*
 Bones 2 2.1 7 4.8 0.489*
 Surgical site 0 0.0 3 2.1
 Central nervous system 1 1.0 0 0.0
 Unknown 11 11.6 21 14.5 0.518
Bacteremia pathogens (n, %)
 Bacteremia with gram‑negative pathogens 44 46.3 58 40.0 0.333
 Bacteremia with gram‑positive pathogens 51 53.7 87 60.0
Details/management of catheter‑related BSI (n, % of catheter‑related BSI)
 Exit site infection 4 14.8 3 8.6 0.689*
 Catheter removal 25 92.6 33 94.3 1.000*
Infectious complications (n, %)
 Ventilator associated pneumonia 1 1.0 6 4.1 0.249*
 Catheter‑related urinary tract infection 1 1.0 0 0.0
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being a predisposing factor for delirium are not fully 
understood. Our finding that males in our cohort were 
suffering more often from delirium than females is in line 
with other studies describing delirium more frequently 
in males in different clinical settings, such as in surgical 
ICUs [28] and in elderly patients of general medical and 
surgical wards [29, 30]. However, other studies of ICU 
populations did not confirm such an association.
A new finding compared to published studies was the 
number of catheters and drainages per patient prior to 
the diagnosis of BSI as another independent predictor of 
new-onset delirium. At first glance, the odds ratio of 1.14 
for delirium by the number of catheters and drainages 
may seem small. However, it has to be taken into account 
that they are given for each additional catheter or drain-
age. Hence, the odds for delirium increases for example 
with two additional catheters by 28%. Given the inher-
ent limitations of observational data, we attempted to 
overcome confounding by including all variables known 
or assumed to impact the emergence of delirium and 
characteristics differing significantly different between 
delirious and non-delirious patients in our cohort into 
the multivariable models. Therefore, the SAPS II score 
and transient episodes of coma [26] prior to BSI diagno-
sis were included in our multivariable models. Three dif-
ferent stepwise model selection techniques were applied, 
all yielding identical results, underlining the robust-
ness of our results. We acknowledge that the associa-
tion between the number of catheters and drainages and 
delirium identified in our cohort may still be confounded 
by unmeasured variables associated with both the use 
of catheters and drainages and delirium. Our result is, 
however, supported by other studies identifying use of 
physical restraints as an important risk factor for the 
development of delirium [31]. Catheters and drainages 
preclude mobilization and have been associated with 
delirium in cardiac surgery patients [32]. Use of restraint 
was identified as a risk factor for delirium in mechanically 
ventilated patients [33] and in a multicenter study of ICU 
patients, which, however, could not assess its independ-
ent predictive value [34]. In our cohort, the use of lines 
was related to delirium despite the fact that all patients 
Table 3 Univariable comparisons of  treatment and  outcome between  ICU patients with  and without  ICDSC ≥4 dur-
ing bloodstream infections (n = 240)
BSI bloodstream infections, ICDSC Intensive Care Delirium Screening Checklist, ICU intensive care unit, IQR interquartile range, GOS Glasgow Outcome Score
Italic: p values are considered significant
Treatment and outcome BSI patients with  
ICDSC <4 (n = 95)




 ICU stay in survivors (days; median, IQR) 4 2–11 10 4–24 0.005
 Hospital stay in survivors (days; median, IQR) 27 16–55 35 21–62 0.224
 Mechanical ventilation (n, %) 91 62.8 50 52.6 0.119
 Mechanical ventilation at BSI onset (n, %) 42 44.2 58 40.0 0.518
 Duration of mechanical ventilation in survivors (days; median, IQR) 10 3–27 9 3–23 0.799
 Number of catheters and drainages (median, IQR) 5 4–7 7 5–10 0.001
 Treatment with neuroleptic drugs for delirium (n, %) 13 13.7 83 57.2 <0.001
 Treatment with anesthetic drugs for delirium (n, %) 48 50.5 100 69.0 0.004
 Treatment with vasopressors (n, %) 38 40.0 54 37.2 0.667
Outcome (n, %)
 Death 22 23.2 59 40.7 0.005
 Return to functional baseline at hospital discharge 44 46.3 44 30.3 0.012
 GOS 1–3 (unfavorable) in survivors 40 54.8 64 74.4 0.010
Fig. 2 Probability of an ICDSC ≥4 during bloodstream infections in 
relation to the number of catheters and drainages. ICDSC Intensive 
Care Delirium Screening Checklist, CI confidence interval
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were subjected to a systemic inflammatory response trig-
gered by bacteremia—another important contributor to 
delirium—underscoring its independent contribution.
Strong systemic inflammatory responses can induce 
acute brain dysfunction. Pro-inflammatory cytokines, 
particularly interleukin (IL)-1beta and tumor necrosis 
factor alpha (TNF-alpha), are produced in the periphery, 
interact with the brain, and initiate cytokine synthesis in 
the central nervous system [35]. Another major hypoth-
eses trying to explain inflammation-related acute brain 
dysfunction is the change in neurotransmitters in rela-
tion to inflammation. In a study of septic animals, the use 
of cholinergic agonists improved cognitive performance 
[36], indicating that cholinergic neurons may be particu-
larly sensitive to systemic inflammation and acute stress-
ors, such as infections, influence the GABA-A complex 
by altering binding sites and modulating the expression 
of selective GABA-A receptor subunits [37].
The results of our study and the examples of patho-
physiologic aspects outlined above suggest a direct 
pathomechanistic link between BSI, systemic inflamma-
tory response and acute brain dysfunction expressed as 
delirium, calling for heightened awareness for new-onset 
delirium in critically ill patients with BSI. The number 
of catheters and drainages in ICU patients may consti-
tute a useful and readily available predictor of delirium 
in patients with BSI allowing to identify patients at high 
risk. Furthermore, the number of catheters and drain-
ages represents a potential target in the prevention of 
delirium, as it seems the number of insertion sites is 
modifiable and likely to further drive delirium in ICU 
patients. While catheters and drainages are inserted for 
specific indications and therefore cannot be omitted in 
most cases, our findings suggest that emphasis should be 
placed on removing such accesses as soon as possible not 
only for prevention of catheter-related infections but also 
for prevention of delirium. In addition, the use of multi-
lumen catheters with the aim of reducing the number 
of insertion sites may be an important consideration in 
patients at high risk for delirium.
Our cohort is representative of other adult ICU popu-
lations, reflected by median age [6, 10, 11, 24, 38], dis-
tribution of gender, the SAPS II [24, 38], the duration of 
delirium [39], the Charlson Comorbidity Index [10, 11, 
38], the proportion of patients with mechanical ventila-
tion [10, 24], ICU stay [10, 38] being similar to prior stud-
ies of delirium in ICU patients. However, mortality was 
higher in our cohort as compared to international epide-
miological multicenter studies of delirium [10, 38], pos-
sibly indicating an intensifying effect on mortality by the 
concurrence of BSI and the genesis of delirium.
The limitations of this study include the observational 
single-center design and the restriction of our cohort to 
the ICUs. Hence, our results are limited to critically ill 
ICU patients. However, demographics, clinical charac-
teristics, and outcomes in our cohort are similar to those 
in prior studies of delirium. Our results that traumatic 
brain injury and dementia were not predictive for the 
emergence of delirium in BSI patients need to be inter-
preted with great caution, as there was only a small num-
ber of dementia and traumatic brain injury in our cohort. 
Our analysis can only provide associations and inference 
regarding causality cannot be drawn. Despite our attempt 
to overcome confounding by using multivariable models 
Table 4 Uni- and multivariable logistic regression analyses of predictors for an ICDSC ≥4 during bloodstream infections 
(n = 240)
BSI bloodstream infections, ICDSC Intensive Care Delirium Screening Checklist, SAPS simplified acute physiology score, SAS Riker Sedation-Agitation Scale, SOFA score 
Sequential [Sepsis-related] Organ Failure Assessment Score
* Stepwise forward and backward selection including all variables presented in the table yielded identical results; italic p values are considered significant
Predictors for ICDSC ≥4 during BSI Univariable Multivariable* (stepwise model 
selection by Akaike information 
criterion)
OR 95% CI p value OR 95% CI p value
Age 1.04 1.02–1.06 <0.001 1.04 1.02–1.06 <0.001
Male gender 2.00 1.14–3.42 0.015 2.26 1.17–4.36 0.015
SAPS II 1.01 0.99–1.03 0.063 – – –
SAS 1.20 1.01–1.42 0.041 1.18 0.96–1.45 0.117
SOFA score 1.06 1.00–1.14 0.059 – – –
Dementia and/or leukoencephalopathy 2.23 0.79–6.31 0.130 – – –
Albumin at admission (for every increasing mg/L) 0.96 0.92–0.99 0.016 – – –
Number of catheters and drainages (for every additional catheter) 1.14 1.05–1.24 0.002 1.14 1.04–1.25 0.004
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including well-established confounders, unmeasured 
residual confounding may have occurred. The fact that 
delirium was diagnosed by using the ICDSC score limits 
the generalizability or our results to studies and cohorts 
examined and rated with the same checklist. However, 
among several screening methods to detect delirium in 
ICUs, the CAM-ICU scale [6] and the ICDSC [9] have 
been most frequently employed. Both have been equally 
recommended for the screening of delirium in ICUs by 
the Society of Critical Care Medicine Pain, Agitation, 
and Delirium guidelines based on high-quality evidence 
[21]. Direct comparisons of the diagnostic accuracy of 
the CAM-ICU and the ICDSC have been performed 
in recent studies with heterogenous ICU populations 
revealing a higher sensitivity and specificity of the ICDSC 
than the CAM-ICU [22–24]. The indications for the 
placement of catheters and drainages may be related 
to the development of delirium in our cohort. How-
ever, the exact indication for the use of catheters could 
not be identified reliably, especially, as in many patients 
several different indications concur. Due to the retro-
spective study design, consecutive data regarding cumu-
lative sedative drug administration could not be assessed. 
However, such information would be critical, as the 
cumulative drug administration does not represent the 
actual individual serum concentrations of the drugs over 
time, as they largely depend on individual factors, such as 
renal or liver function, and body weight. In addition, indi-
vidual drug sensitivity would not be addressed. We fur-
ther acknowledge that despite daily stopping of sedation 
and the use of short acting anesthetics, a slight remain-
ing sedative effect may have still influenced the ICDSC 
assessment—a shortcoming that can only be overcome by 
excluding mechanically ventilated and sedated patients 
resulting in a highly selected population not representa-
tive of general ICU populations.
Conclusions
The incidence of new-onset delirium in critically ill 
patients with BSI is high and associated with increased 
mortality and unfavorable outcome in survivors call-
ing for heightened awareness and rigorous screening 
for delirium in patients with BSI during intensive care. 
Older age, male gender, and the number of catheters and 
drainages are independent predictors of delirium in close 
temporal association with BSI. The number of catheters 
and drainages may constitute a useful and readily avail-
able predictor of delirium in patients with BSI allowing to 
identify patients at high risk. Further studies are needed 
to externally validate our findings. Ultimately, reliable 
identification of patients at increased risk of delirium is 
key for allocation of specific prevention strategies.
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